Lifeboat Foundation

German Party for Health Research is calling for more funding for studies on aging and age-related diseases! Nice initiative! Good luck!

It seems the only reason why the situation with state funding for medical research has not improved over time in a given country is the lack of well-organized public initiatives to support the necessary changes.

Continue reading “German Party for Health Research: Together Against Age-related Diseases” »

Transhumanism discussion of using implants in children is in The Sun today, one of UK’s largest sites/papers.

A DOCTOR known as a “human cyborg” has revealed parents are bombarding him with requests to implant chips into their children.

Dr Patrick Kramer, who work under the job title of “chief cyborg officer”, receives harrowing messages from parents desperate for him to implant tracking chips under their children’s skin.

Continue reading “Mum begged doc to ‘chip’ daughter in case ‘radical’ dad takes her to Syria” »

A Soviet officer who prevented a nuclear crisis between the US and the USSR and possible World War III in the 1980s has quietly passed away. He was 77. In 2010 RT spoke to Stanislav Petrov, who never considered himself a hero. We look at the life of the man who saved the world.

A decision that Soviet lieutenant colonel Stanislav Petrov once took went down in history as one that stopped the Cold War from turning into nuclear Armageddon, largely thanks to Karl Schumacher, a political activist from Germany who helped the news of his heroism first reach a western audience nearly two decades ago.

Continue reading “‘I was just doing my job’: Soviet officer who averted nuclear war dies at age 77” »

The therapy has been approved by the FDA for phase one clinical trials at three U.S. institutions: the Greenebaum Cancer Center of the University of Maryland, the Medical University of South Carolina and the University of Virginia Cancer Center.

Detailed study of how Cas9 protein domains move when they bind DNA leads to re-engineered Cas9 with fewer off-target effects.

Researchers studied 14,000 Icelanders and found that men passed on one new mutation for every eight months of age, compared with women who passed on a new mutation for every three years of age.

The figures mean that a child born to 30-year-old parents would, on average, inherit 11 new mutations from the mother, but 45 from the father.

Solar and wind power are all about the batteries.

The age of batteries is just getting started. In the latest episode of our animated series, Sooner Than You Think, Bloomberg’s Tom Randall does the math on when solar plus batteries might start wiping fossil fuels off the grid.

We have some breaking news from the IHPC Forum in Guangzhou today. Researchers in China are busy upgrading the MilkyWay 2 (Tianhe-2) system to nearly 95 Petaflops (peak). This should nearly double the performance of the system, which is currently ranked at #2 on TOP500 with 33.86 Petaflops on the Linpack benchmark. The upgraded system, dubbed Tianhe −2A, should be completed in the coming months.

Details about the system upgrade were presented at the conference opening session. While the current system derives much of its performance from Intel Knights Corner co-processors, the new system swaps these PCI devices out for custom-made 4-way MATRIX-200o boards, with each chip providing 2.46 Teraflops of peak performance.

Continue reading “China Upgrading Milky Way 2 Supercomputer to 95 Petaflops” »

The cost of drug discovery and subsequent development is a massive challenge in the pharmaceutical industry. A typical drug can cost upwards of $2.5 billion and a decade or more to identify and test a new drug candidate[1].

These costs have been increasing steadily over the years, and pharmaceutical manufacturers are constantly seeking ways to improve efficiency to save time and money and speed up research progress.

Automation in the lab is one example; tasks that were traditionally carried out by technicians can now be done by machines. Increasingly sophisticated assays to detect new drug candidates have also helped to slash development time. Now a new ally has arrived to aid drug development – artificial intelligence – and a powerful ally it is.